These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. The immune system in experimental Pseudomonas keratitis. Model and early effects. Twining SS; Lohr KM; Moulder JE Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):507-15. PubMed ID: 3082789 [TBL] [Abstract][Full Text] [Related]
5. Immunological study of glycolipoprotein isolated from extracellular slime of different Pseudomonas aeruginosa serogroups. Stanislavsky ES; Kholodkova EV; Youshkova NA; Yourokova IB; Zhvanetskaya MI Acta Microbiol Hung; 1986; 33(1):55-67. PubMed ID: 3092559 [TBL] [Abstract][Full Text] [Related]
6. A partial-thickness epithelial defect increases the adherence of Pseudomonas aeruginosa to the cornea. Klotz SA; Au YK; Misra RP Invest Ophthalmol Vis Sci; 1989 Jun; 30(6):1069-74. PubMed ID: 2499555 [TBL] [Abstract][Full Text] [Related]
7. Carbohydrate mediation of the biological activities of the glycolipoprotein of Pseudomonas aeruginosa. Orr T; Koepp LH; Bartell PF J Gen Microbiol; 1982 Nov; 128(11):2631-8. PubMed ID: 6818328 [TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of experimental Pseudomonas keratitis in the guinea pig: bacteriologic, clinical, and microscopic observations. Van Horn DL; Davis SD; Hyndiuk RA; Alpren TV Invest Ophthalmol Vis Sci; 1978 Nov; 17(11):1076-86. PubMed ID: 100468 [TBL] [Abstract][Full Text] [Related]
9. Biochemical alterations in the mouse induced by Pseudomonas aeruginosa and its slime glycolipoprotein. Lynn M; Lotz L Br J Exp Pathol; 1984 Apr; 65(2):275-81. PubMed ID: 6424696 [TBL] [Abstract][Full Text] [Related]
10. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection. Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605 [TBL] [Abstract][Full Text] [Related]
11. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida. Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960 [TBL] [Abstract][Full Text] [Related]
12. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model. Cole N; Willcox MD; Fleiszig SM; Stapleton F; Bao B; Tout S; Husband A Curr Eye Res; 1998 Jul; 17(7):730-5. PubMed ID: 9678419 [TBL] [Abstract][Full Text] [Related]
13. Pseudomonas aeruginosa protease IV produces corneal damage and contributes to bacterial virulence. Engel LS; Hill JM; Moreau JM; Green LC; Hobden JA; O'Callaghan RJ Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):662-5. PubMed ID: 9501882 [TBL] [Abstract][Full Text] [Related]
14. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis. Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951 [TBL] [Abstract][Full Text] [Related]
15. Serologic and protective cross-reactivity of antisera to Pseudomonas aeruginosa extracellular slime glycolipoprotein. Yushkova NA; Kholodkova EV; Korobova TS; Stanislavsky ES Acta Microbiol Hung; 1986; 33(2):147-56. PubMed ID: 3101393 [TBL] [Abstract][Full Text] [Related]
17. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis. Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931 [TBL] [Abstract][Full Text] [Related]
18. Identification of a novel secreted protease from Pseudomonas aeruginosa that causes corneal erosions. Marquart ME; Caballero AR; Chomnawang M; Thibodeaux BA; Twining SS; O'Callaghan RJ Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3761-8. PubMed ID: 16186360 [TBL] [Abstract][Full Text] [Related]
19. Pathogenesis of corneal damage from pseudomonas exotoxin A. Iglewski BH; Burns RP; Gipson IK Invest Ophthalmol Vis Sci; 1977 Jan; 16(1):73-6. PubMed ID: 401777 [TBL] [Abstract][Full Text] [Related]
20. Activation of the alternative pathway of human complement by the extracellular slime glycolipoprotein of Pseudomonas aeruginosa. Lambris J; Papamichail M; Ioannidis C; Dimitracopoulos G J Infect Dis; 1982 Jan; 145(1):78-82. PubMed ID: 6798132 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]